Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

TNF-alpha inhibitors can cause various immune-related skin issues.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Some drugs used to treat inflammation may cause hair loss.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Older patients sticking to their prostate medication saw lasting health benefits.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Finasteride improves heart function in obese and aging male rats by reducing oxidative stress and p53 protein levels.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Some drugs used to treat immune conditions may cause different types of hair loss.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Dupilumab for skin problems might reactivate hair loss in some patients.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.